Chuang E - Search Results

1

A phase II dose ranging, double-blind, placebo-controlled study of alicaforsen enema in subjects with acute exacerbation of mild to moderate left-sided ulcerative colitis.

van Deventer SJ, Wedel MK, Baker BF, Xia S, Chuang E, Miner PB Jr. van Deventer SJ, et al. Among authors: chuang e. Aliment Pharmacol Ther. 2006 May 15;23(10):1415-25. doi: 10.1111/j.1365-2036.2006.02910.x. Aliment Pharmacol Ther. 2006. PMID: 16669956 Clinical Trial.

2

Bioavailability and therapeutic activity of alicaforsen (ISIS 2302) administered as a rectal retention enema to subjects with active ulcerative colitis.

Miner PB Jr, Geary RS, Matson J, Chuang E, Xia S, Baker BF, Wedel MK. Miner PB Jr, et al. Among authors: chuang e. Aliment Pharmacol Ther. 2006 May 15;23(10):1427-34. doi: 10.1111/j.1365-2036.2006.02909.x. Aliment Pharmacol Ther. 2006. PMID: 16669957 Clinical Trial.

3

Potent reduction of apolipoprotein B and low-density lipoprotein cholesterol by short-term administration of an antisense inhibitor of apolipoprotein B.

Kastelein JJ, Wedel MK, Baker BF, Su J, Bradley JD, Yu RZ, Chuang E, Graham MJ, Crooke RM. Kastelein JJ, et al. Among authors: chuang e. Circulation. 2006 Oct 17;114(16):1729-35. doi: 10.1161/CIRCULATIONAHA.105.606442. Epub 2006 Oct 9. Circulation. 2006. PMID: 17030687 Clinical Trial.

4

A randomized, double-masked, placebo-controlled study of alicaforsen, an antisense inhibitor of intercellular adhesion molecule 1, for the treatment of subjects with active Crohn's disease.

Yacyshyn B, Chey WY, Wedel MK, Yu RZ, Paul D, Chuang E. Yacyshyn B, et al. Among authors: chuang e. Clin Gastroenterol Hepatol. 2007 Feb;5(2):215-20. doi: 10.1016/j.cgh.2006.11.001. Clin Gastroenterol Hepatol. 2007. PMID: 17296530 Clinical Trial.

5

Randomised clinical trial: alosetron improves quality of life and reduces restriction of daily activities in women with severe diarrhoea-predominant IBS.

Cremonini F, Nicandro JP, Atkinson V, Shringarpure R, Chuang E, Lembo A. Cremonini F, et al. Among authors: chuang e. Aliment Pharmacol Ther. 2012 Sep;36(5):437-48. doi: 10.1111/j.1365-2036.2012.05208.x. Epub 2012 Jul 10. Aliment Pharmacol Ther. 2012. PMID: 22779693 Free PMC article. Clinical Trial.

6

Randomised clinical trial: safety, pharmacokinetics and pharmacodynamics of trazpiroben (TAK-906), a dopamine D₂ /D₃ receptor antagonist, in patients with gastroparesis.

Kuo B, Scimia C, Dukes G, Zhang W, Gupta S, Chen C, Chuang E, Camilleri M. Kuo B, et al. Among authors: chuang e. Aliment Pharmacol Ther. 2021 Aug;54(3):267-280. doi: 10.1111/apt.16451. Epub 2021 Jun 20. Aliment Pharmacol Ther. 2021. PMID: 34148244 Clinical Trial.

7

A biomarker panel and psychological morbidity differentiates the irritable bowel syndrome from health and provides novel pathophysiological leads.

Jones MP, Chey WD, Singh S, Gong H, Shringarpure R, Hoe N, Chuang E, Talley NJ. Jones MP, et al. Among authors: chuang e. Aliment Pharmacol Ther. 2014 Feb;39(4):426-37. doi: 10.1111/apt.12608. Epub 2014 Jan 6. Aliment Pharmacol Ther. 2014. PMID: 24387672 Free article.

8

Evaluation of treatment continuation with alosetron by IBS-D severity criteria.

Nicandro JP, Shin P, Chuang E. Nicandro JP, et al. Among authors: chuang e. Curr Med Res Opin. 2012 Mar;28(3):449-56. doi: 10.1185/03007995.2011.653435. Epub 2012 Feb 7. Curr Med Res Opin. 2012. PMID: 22313141

9

Alosetron versus traditional pharmacotherapy in clinical practice: effects on resource use, health-related quality of life, safety and symptom improvement in women with severe diarrhea-predominant irritable bowel syndrome.

Olden KW, Chey WD, Shringarpure R, Paul Nicandro J, Chuang E, Earnest DL. Olden KW, et al. Among authors: chuang e. Curr Med Res Opin. 2019 Mar;35(3):461-472. doi: 10.1080/03007995.2018.1533456. Epub 2018 Nov 22. Curr Med Res Opin. 2019. PMID: 30293448

10

A 9-year evaluation of temporal trends in alosetron postmarketing safety under the risk management program.

Tong K, Nicandro JP, Shringarpure R, Chuang E, Chang L. Tong K, et al. Among authors: chuang e. Therap Adv Gastroenterol. 2013 Sep;6(5):344-57. doi: 10.1177/1756283X13491798. Therap Adv Gastroenterol. 2013. PMID: 24003335 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

535 results

Search Page

Filters